Turkish President Meets with Immunotherapy Company Founder

Turkish President Recep Tayyip Erdogan met with the founder of ImmunityBio (IBRX), William Hale, at his private villa in Istanbul. The meeting drew speculation about potential partnerships and investments in the company’s immunotherapy treatments. Hale discussed the company’s ongoing research into new cancer therapies, including an experimental treatment for kidney cancer that has shown promising results in early-stage trials. The meeting with Erdogan is seen as a significant development for ImmunityBio, which has been looking to expand its global reach and access to new markets. The company has already established partnerships with several major pharmaceutical companies, but a meeting with the Turkish president could pave the way for additional collaborations. Shares of ImmunityBio rose 10% following the news of the meeting, as investors speculated about potential deals and the impact on the company’s growth prospects. Note: No further information was available to rewrite.